
Actress, Universa
Danai Gurira
Actress | Universa
About Danai
Danai Jekesai Gurira is a Zimbabwean-American actress, playwright, screenwriter, producer, and activist born on February 14, 1978. She is known for her starring roles as Michonne in the AMC horror drama franchise The Walking Dead and as Okoye in the Marvel Cinematic Universe. Her work in film has contributed to a total gross of 6.98 billion dollars, making her the seventh highest-grossing actress of all time. As a playwright, Gurira authored the play In the Continuum, which earned her an Obie Award. She also wrote The Convert, Familiar, and Eclipsed. The latter was nominated for six Tony Awards, including Best Play. On screen, she wrote an episode of the 2024 spin-off The Walking Dead: The Ones Who Live that focused on her characters Michonne and Rick Grimes. This episode received critical acclaim, and Gurira was nominated for a Black Reel TV Award for Outstanding Writing in a Drama Series. Beyond her acting and writing, she has been a UN Women Goodwill Ambassador since 2018 and has founded two non-profit organizations. In 2023, she received the TIME100 Impact Award. She established Gurazoo Productions, a production company with an overall television deal with ABC Studios.
Summary based on Wikipedia, available under CC BY-SA.
Latest interviews
Every podcast episode Danai Gurira has appeared on, newest first.
Speaks about
Topics hosts book Danai to cover, drawn from the episodes where they appear.
Appeared On
Browse the full historical catalogue of shows that have previously hosted Danai.
Guests who appear alongside
Guests who share the same shows as Danai. Worth a look if you are building a panel or pitching the same circuit.
Browse related cuts
This profile is auto-generated from publicly available podcast episode metadata. Is this profile about you? Request removal or email privacy@pitchcentric.com.
FAQs
Every question we get asked before
someone starts their trial.
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
What is the difference between Founder Solo and Founder Pro?
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
How do agency tiers work?
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
What is a talent profile?
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Can I switch plans later?
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Do you offer a free trial?
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
What happens if I cancel?
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Is the 20% annual discount automatic?
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
What if I have more than 50 profiles or 20 clients?
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.







